WHO ICTRP trial
Efficacy of steroid therapy for primary prevention of cerebral amyloid…
JPRN-UMIN000013120 · Japan Primary Registries Network (JPRN) · Not Recruiting
Key facts
| Trial ID | JPRN-UMIN000013120 |
|---|---|
| Public title | Efficacy of steroid therapy for primary prevention of cerebral amyloid angiopathy-related hemorrhage. |
| Scientific title | Efficacy of steroid therapy for primary prevention of cerebral amyloid angiopathy-related hemorrhage. - Efficacy of steroid therapy for primary prevention of cerebral amyloid angiopathy-related hemorrhage. |
| Primary sponsor | Aizawa Hospital |
| Registry | Japan Primary Registries Network (JPRN) |
| Recruitment status | Not Recruiting |
| Study type | Interventional |
| Phase | Not selected |
| Countries | Japan |
| Conditions | Cerebral amyloid angiopathy |
| Interventions | Non-steroid group Observational period <=18 months 2.5mg prednisolone group Observational period <=18 months, daily administration 10mg prednisolone group Observational period <=18 months, daily administration |
| Registration date | Oct 2, 2014 |
| Target size | 10 |
| Registry page | center6.umin.ac.jp |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: